(Treffer aus pharmind, Nr. 07, Seite 1008 (2016))
Packowski J | Dayazada M | Lenhardt M
Game Changer Iran / The Pharmaceutical Market in the Gulf Region · Packowski J, Dayazada M, Lenhardt M · 1
CAMELOT Management Consultants AG, Mannheim, Germany und 2
Dubai, United Arab Emirates
With a projected annual growth rate of 9.2 % by 2020 the Gulf States 1) are one of the fastest growing pharmaceutical markets in the world. The majority of the Gulf States, comprising mainly the 6 “Gulf Cooperation Council” (GCC) states Bahrain, Kuwait, Qatar, United Arab Emirates (UAE), Saudi Arabia and Oman plus Iran, are importers of patented pharmaceutical products, with overall imports contributing around 70 to 85 % of total consumption. However, certain markets in the Middle East (e.g. Jordan, Egypt, and Saudi Arabia) have a generic drugs manufacturing market, which is continually growing along with the changing demographics in ...